EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) has unveiled its West Synchrony™ Prefillable Syringe (PFS) System, a new platform designed to simplify and accelerate the drug development process for biologics and vaccines. Introduced last week at CPHI Worldwide in Frankfurt, Germany, the Synchrony system will be commercially available in January 2026.
The system delivers what West describes as the industry’s first fully verified, system-level prefillable syringe solution from a single supplier. It offers integrated performance and regulatory data to streamline syringe selection, reduce delays, and improve supply chain reliability—key concerns for pharmaceutical companies developing complex biologic therapies.
Andy Polywacz, President of Integrated Systems at West, said the new platform addresses a long-standing challenge in drug development. “Leaders in drug development face pressures to meet milestones efficiently amid complex challenges, amongst them, selecting prefillable syringes,” Polywacz explained. “They currently rely on fragmented approaches—assembling component data from multiple suppliers or outsourcing piecemeal verification, which risks delays, increased costs and regulatory setbacks. With the West Synchrony prefillable syringe system, it enables pharmaceutical companies to streamline design, accelerate regulatory submission, and secure a reliable supply chain for combination products that meets quality and volume needs.”
Streamlined Design and Regulatory Integration
The West Synchrony PFS system is built around three core benefits:
- System-Level Design Verification: A single, validated design and characterization package ensures full compatibility and performance across the syringe system.
- Simplified Regulatory Submissions: West provides a unified drug master file and comprehensive regulatory package to expedite global approvals.
- Single-Source Reliability: The solution consolidates manufacturing and supply under one provider, offering both make-to-stock and make-to-order options with low minimum quantities.
The company said the Synchrony system represents a “significant evolution” in injectable drug delivery, giving pharmaceutical firms a ready-to-deploy solution that meets modern standards for quality, efficiency, and patient safety.
With demand for biologics and combination products rising worldwide, West’s new system positions the company at the forefront of innovation in prefilled syringe technology—reducing complexity for developers while ensuring scalable, regulatory-ready performance from lab to market.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.